SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (2782)11/14/1997 7:48:00 PM
From: Oliver & Co  Read Replies (1) of 6136
 
My position is that every patient has to be offered the best possible therapy, no questions asked. However, we must take care and instruct the patient (which is not very well done). I always give the patients the recommendations, then is up to them to follow them. I try to help them out with the coverage, but there is not much more than we can do. We do not have any HMO patients, because it was a constant uphill battle. We are lucky that Florida Medicaid covers "all antiretrovirals". The ones we have problems with are the ones with ins/HMO.
Hit hard, hit early is by far the best choice. But the patient has to be part of the treatment. We can not just hand them a prescription, and say, come back in three months.

JLL

Thanks,

JLL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News